Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Washer 

Boston Scientific diskutieren

Boston Scientific

WKN: 884113 / Symbol: BSX / Name: Boston Scient / Aktie / Ausrüstung & Versorgung / Large Cap /

69,00 €
-0,72 %

Buy Boston Scientific

Einschätzung Buy
Rendite (%) 44,56 %
Kursziel 54,08
Veränderung
Endet am 30.05.24

Boston Scientific Co. (NYSE: BSX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $58.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 39,70 %
Kursziel 58,68
Veränderung
Endet am 30.06.24

Boston Scientific Co. (NYSE: BSX) is now covered by analysts at CL King. They set a "buy" rating and a $64.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Boston Scientific Co. (NYSE: BSX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 45,32 %
Kursziel 55,39
Veränderung
Endet am 28.07.24

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Needham & Company LLC from $57.00 to $61.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 47,97 %
Kursziel 55,60
Veränderung
Endet am 11.08.24

Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $61.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 38,75 %
Kursziel 58,28
Veränderung
Endet am 28.08.24

Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Citigroup Inc.. They now have a $63.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 38,75 %
Kursziel 56,43
Veränderung
Endet am 28.08.24

Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $61.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 38,75 %
Kursziel 53,66
Veränderung
Endet am 28.08.24

Boston Scientific Co. (NYSE: BSX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $58.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 35,93 %
Kursziel 56,85
Veränderung
Endet am 11.09.24

Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $61.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 38,97 %
Kursziel 56,11
Veränderung
Endet am 19.09.24

Boston Scientific Co. (NYSE: BSX) had its "outperform" rating re-affirmed by analysts at Evercore ISI. They now have a $60.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 34,40 %
Kursziel 57,00
Veränderung
Endet am 20.09.24

Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $61.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 35,93 %
Kursziel 60,02
Veränderung
Endet am 21.09.24

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at BTIG Research from $62.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 35,93 %
Kursziel 57,21
Veränderung
Endet am 21.09.24

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Royal Bank of Canada from $58.00 to $61.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 35,93 %
Kursziel 59,08
Veränderung
Endet am 21.09.24

Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Citigroup Inc.. They now have a $63.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 35,93 %
Kursziel 57,16
Veränderung
Endet am 21.09.24

Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $61.00 price target on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 47,25 %
Kursziel 56,83
Veränderung
Endet am 27.10.24

Boston Scientific Co. (NYSE: BSX) had its price target lowered by analysts at Needham & Company LLC from $65.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 35,40 %
Kursziel 56,30
Veränderung
Endet am 04.12.24

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Morgan Stanley from $58.00 to $61.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 33,98 %
Kursziel 60,31
Veränderung
Endet am 12.12.24

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at TD Cowen from $58.00 to $65.00. They now have an "outperform" rating on the stock.
Ratings data for BSX provided by MarketBeat

Einschätzung Buy
Rendite (%) 32,90 %
Kursziel 57,46
Veränderung
Endet am 13.12.24

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Wells Fargo & Company from $59.00 to $62.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat